WeVote
Log In

Bill

Bill

HB 3912

Insurance; health benefit plans; scalp cooling systems; notice of coverage; Insurance Commissioner; effective date.

2026 Regular Session Introduced by Mickey Dollens

Oklahoma law requiring health insurers to notify patients about scalp cooling system coverage during chemotherapy, with Insurance Commissioner oversight of compliance.

Referred to Insurance
0
WeVote Research Nonpartisan
Bill Summary · HB 3912

Legislative bill overview

HB 3912 requires health insurance plans in Oklahoma to provide notice regarding coverage of scalp cooling systems, which are devices used to reduce hair loss during chemotherapy treatment. The bill also directs the Insurance Commissioner to oversee compliance with these notice requirements and establishes an effective date for implementation.

Why is this important

Scalp cooling systems can significantly improve quality of life for cancer patients undergoing chemotherapy by reducing or preventing hair loss, a visible side effect that affects emotional well-being and social confidence. Ensuring patients know whether their insurance covers this technology removes a barrier to access and allows informed treatment decisions. The bill addresses a healthcare equity issue by guaranteeing transparent information about a specific medical device benefit.

Potential points of contention

  • Cost implications: Mandating notice requirements may pressure insurers to expand coverage of scalp cooling systems, which are expensive devices ($3,000-$5,000+ per treatment), potentially increasing premiums
  • Coverage scope uncertainty: The bill doesn't specify whether insurers must actually cover scalp cooling systems or merely notify patients about existing coverage policies, creating ambiguity about the intended regulatory burden
  • Administrative burden: Health plans would need to update notices and documentation, with the Insurance Commissioner responsible for enforcement and compliance monitoring

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.